Skip to main content
CSL
  • Global Selector
  • Newsroom
  • Partnering
  • Contact
  • We Are CSL
    We Are CSL
    Our Businesses and Products
    Vita: Original Stories
    Our Leadership
    Worldwide Locations
    Corporate Governance
    Our Businesses and Products
    CSL Behring
    CSL Seqirus
    CSL Vifor
    Corporate Governance
    Code of Responsible Business Practice
    Core Policies

    Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.

    Read the Stories

    CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.

    Our Businesses and Products
  • Patients & Public Health
    Patients & Public Health
    Rare & Serious Diseases
    Iron Deficiency
    Nephrology
    Vaccines
    Patient Support & Organizations
    Rare & Serious Diseases
    Immunodeficiency and Autoimmune Diseases
    Hereditary Bleeding Disorders
    Hereditary Angioedema
    Alpha 1 Antitrypsin Deficiency
    Iron Deficiency
    Iron Deficiency Patient Stories
    Nephrology
    Nephrology Patient Stories
    Vaccines
    COVID-19
    Pandemic Response
    In-Licensing
    Antivenoms and Q fever Vaccine
    Patient Support & Organizations
    CSL Behring USA Support & Assistance Programs
    CSL Vifor Managed Access Programs
    LEAD Grants

    Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.

    CSL Behring: Rare & Serious Diseases

    Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.

    CSL Seqirus: Vaccines
  • R&D
    R&D
    R&D Capabilities
    Awards, Grants and Initiatives
    World-Class R&D Network
    Product Pipeline
    Clinical Studies at CSL
    Clinical Studies at CSL
    Current Clinical Trials
    Research Practices
    How to Participate
    Clinical Studies FAQs

    R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.

    R&D Capabilities

    One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.

    Awards, Grants and Initiatives
  • Sustainability
    Sustainability
    Healthier Environment
    Healthier Communities
    Promising Futures
    Governance
    Data and Reporting Centre
    Healthier Environment
    Climate Resilience
    Energy
    Water and Waste
    Healthier Communities
    Product Safety & Quality
    Innovation and R&D
    Access and Affordability
    Responsible & Resilient Supply Chain
    Donor Experience
    Patient Experience
    Promising Futures
    Talent and Culture
    Health, Safety & Wellbeing
    Inclusion and Belonging
    Governance
    Ethics & Transparency
    Data Protection & Privacy
    Stakeholder Engagement & Material Topics
    Data and Reporting Centre
    Annual Publications
    Policies
    Key Performance Data Summary

    As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.

    Learn About Our Targets

    Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.

    Supporting Our Communities
  • Careers
    Careers
    Diversity, Equity & Inclusion
    How CSL Supports Your Well-being
    Early Careers at CSL
    Early Careers at CSL
    Apprenticeships
    Internships at CSL
    Graduate Rotational Programs at CSL

    At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.

    Read About Our DE&I

    Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!

    Early Careers at CSL
  • Investors
CSL

  • We Are CSL
    • We Are CSL
    • Our Businesses and Products
      • Our Businesses and Products
      • CSL Behring
      • CSL Seqirus
      • CSL Vifor
    • Vita: Original Stories
    • Our Leadership
    • Worldwide Locations
    • Corporate Governance
      • Corporate Governance
      • Code of Responsible Business Practice
      • Core Policies
  • Patients & Public Health
    • Patients & Public Health
    • Rare & Serious Diseases
      • Rare & Serious Diseases
      • Immunodeficiency and Autoimmune Diseases
      • Hereditary Bleeding Disorders
      • Hereditary Angioedema
      • Alpha 1 Antitrypsin Deficiency
    • Iron Deficiency
      • Iron Deficiency
      • Iron Deficiency Patient Stories
    • Nephrology
      • Nephrology
      • Nephrology Patient Stories
    • Vaccines
      • Vaccines
      • COVID-19
      • Pandemic Response
      • In-Licensing
      • Antivenoms and Q fever Vaccine
    • Patient Support & Organizations
      • Patient Support & Organizations
      • CSL Behring USA Support & Assistance Programs
      • CSL Vifor Managed Access Programs
      • LEAD Grants
  • R&D
    • R&D
    • R&D Capabilities
    • Awards, Grants and Initiatives
    • World-Class R&D Network
    • Product Pipeline
    • Clinical Studies at CSL
      • Clinical Studies at CSL
      • Current Clinical Trials
      • Research Practices
      • How to Participate
      • Clinical Studies FAQs
  • Sustainability
    • Sustainability
    • Healthier Environment
      • Healthier Environment
      • Climate Resilience
      • Energy
      • Water and Waste
    • Healthier Communities
      • Healthier Communities
      • Product Safety & Quality
      • Innovation and R&D
      • Access and Affordability
      • Responsible & Resilient Supply Chain
      • Donor Experience
      • Patient Experience
    • Promising Futures
      • Promising Futures
      • Talent and Culture
      • Health, Safety & Wellbeing
      • Inclusion and Belonging
    • Governance
      • Governance
      • Ethics & Transparency
      • Data Protection & Privacy
      • Stakeholder Engagement & Material Topics
    • Data and Reporting Centre
      • Data and Reporting Centre
      • Annual Publications
      • Policies
      • Key Performance Data Summary
  • Careers
    • Careers
    • Diversity, Equity & Inclusion
    • How CSL Supports Your Well-being
    • Early Careers at CSL
      • Early Careers at CSL
      • Apprenticeships
      • Internships at CSL
      • Graduate Rotational Programs at CSL
  • Investors
  • Newsroom
  • Partnering
  • Contact
  • Global Selector

What Is Iron Deficiency Day?

Since 2015, CSL Vifor has marked Iron Deficiency Day on 26 November to shine a light on a global health concern: iron deficiency and iron deficiency anemia (IDA).

Learn About This Annual Event

We have released our 2024 Annual Report Click here to read the Annual Report →   |    We have announced our 2024 Full Year Financial Results for the period ending June 30th 2024. Click here to view Information and Webcast Recording →

CSL
CSL Behring
CSL Seqirus
CSL Vifor

CSL. Always Evolving for a Better World.

CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.

Our Businesses and Products

CSL Behring. Leading the Way in Treating Rare and Serious Diseases.

CSL Behring is a global biotech leader with a broad range of biotherapies for rare and serious diseases including bleeding disorders, immunodeficiencies, hereditary angioedema, neurological disorders and Alpha 1 Antitrypsin Deficiency.

More About CSL Behring

CSL Seqirus. Global Vaccine Leader.

Through the power of innovation, our vision is to advance science to enhance public health worldwide. We stand on the front line with partners in public health discovering, developing, and delivering pioneering vaccine solutions to safeguard people and communities across the world.

More About CSL Seqirus

CSL Vifor. Changing the Game in Iron Deficiency and Nephrology.

The newest member of the CSL family, CSL Vifor is a global leader in iron deficiency and nephrology and is committed to launching the next generation of therapies to truly address the full spectrum of kidney disease, with a focus on dialysis and rare disease.

More About CSL Vifor
CSL Logo The text 'CSL' in bold white all capitals.
CSL Behring Logo The text 'CSL Behring' in bold white.
CSL Seqirus Logo The text 'CSL Seqirus' in bold white.
CSL Vifor Logo The text 'CSL Vifor' in bold white.
CSL Logo

CSL. Always Evolving for a Better World.

CSL has delivered biotechnology excellence for over a century. Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need. We’re always improving so life can, too.

Our Businesses and Products
CSL Behring Logo

CSL Behring. Leading the Way in Treating Rare and Serious Diseases.

CSL Behring is a global biotech leader with a broad range of biotherapies for rare and serious diseases including bleeding disorders, immunodeficiencies, hereditary angioedema, neurological disorders and Alpha 1 Antitrypsin Deficiency.

More About CSL Behring
CSL Seqirus Logo

CSL Seqirus. Global Vaccine Leader.

Through the power of innovation, our vision is to advance science to enhance public health worldwide. We stand on the front line with partners in public health discovering, developing, and delivering pioneering vaccine solutions to safeguard people and communities across the world.

More About CSL Seqirus
CSL Vifor Logo

CSL Vifor. Changing the Game in Iron Deficiency and Nephrology.

The newest member of the CSL family, CSL Vifor is a global leader in iron deficiency and nephrology and is committed to launching the next generation of therapies to truly address the full spectrum of kidney disease, with a focus on dialysis and rare disease.

More About CSL Vifor

Vita: Original Stories

'Vita' means life. It's also where we share the stories of biotech's promise to patients and public health.

A team of CSL Behring employees join Dee, an Alpha-1 Antitrypsin Deficiency patient, in her trek up Mt. Rainier in Washington state in the United States.

Alpha-1 Trailblazers

During Alpha-1 Awareness Month, get inspired by the forward-moving, always-reaching Alpha-1 Antitrypsin Deficiency community.…

18 Nov 2024
Young woman with white writing on her face that says take iron seriously

Explainer: What Is Iron Deficiency Day?

Since 2015, CSL Vifor has marked Iron Deficiency Day on 26 November to shine a light on a global health concern: iron deficie…

07 Nov 2024
Illustration of cell with pullout image of an X-shaped chromosome

Video: What Are Chromosomes, DNA and Genes?

Inside your cells, these essential elements contain specific instructions – and that’s why they’re the target of 21st century…

18 Oct 2024
CSL scientist in Switzerland

Careers at CSL

We are committed to helping employees fulfill their career aspirations while working in a values-based culture. Are you next?

Pictured: CSL employees in Melbourne, Australia

Promising Futures at CSL

CSL on LinkedIn

Follow us!
LinkedIn
20 Nov

For over a century, CSL has supported Australia through seasonal flu and five pandemics via onshore manufacturing and domestic vaccine capacity building. Our state-of-the-art facility in Melbourne, Australia will soon be the heart of Australian seasonal and pandemic influenza vaccine production, and we were proud to welcome Health Minister The Hon Mark Butler MP to tour the site and see our next-generation capabilities. Learn more about what we do at CSL: https://bit.ly/3CFM4Hx #Vaccines #Influenza #PublicHealth #Manufacturing #Melbourne #Australia #DrivenByOurPromise #CSLSeqirus

LinkedIn
20 Nov

We were honored to host Massachusetts Public Health Committee Chairwoman Representative Marjorie Decker and Vice-chairwoman Representative Sally Kerans, Representative Vanna Howard, as well as their teams, and the office of Senator John Keenan for a tour of our Waltham, MA R&D site. Their visit was a testament to their commitment to public health, and we are grateful for their interest in our work. Learn more about CSL https://bit.ly/3YW2x1Q. #CSL

LinkedInPostImage
LinkedIn
18 Nov

Did you know that CKD-aP, a relentless itch affecting up to 70% of dialysis patients, is often overlooked despite its profound impact on quality of life? At CSL Vifor, we’re driving awareness and championing patient-centered care for those affected by this condition. In a recent article for The Parliament Magazine, we highlighted the importance of understanding patient-reported outcomes to address CKD-aP's impact. Joining the conversation, Daniel Gallego, President of the European Kidney Patients’ Federation, shares six actionable recommendations to enhance care for CKD-aP across Europe. Let’s make CKD-aP a priority in kidney care—together, we can go #BeyondItching to improve patients’ lives. Read more https://bit.ly/3UWfIi7

LinkedInPostImage
LinkedIn
14 Nov

🥩🥬 Looking for ways to boost your iron levels through your diet? Iron-rich food could be a way to boost your iron levels. Here are some foods that could support you: -Red meat and poultry -Leafy greens \(like spinach and kale\) -Lentils and beans -Fortified cereals -Nuts and seeds Pairing iron-rich foods with vitamin C \(found in oranges, peppers, and tomatoes\) can help your body absorb iron better! Make sure you always check and consult with your doctor first. What’s your go-to iron-boosting snack? Share with us in the comments! Visit https://bit.ly/3Cu8U4U to learn more. #TakeIronSeriously #IronDeficiency #Nutrition #HealthTips #IronDeficiencyDay2024

LinkedInPostImage
LinkedIn
13 Nov

This World Kindness Day, why not share the gift of life? For our friends in the U.S., donating plasma is a simple act of kindness that can make a world of difference for patients in need. Your donation helps create lifesaving therapies for people with rare and serious diseases. #WorldKindnessDay #DonatePlasma Find a CSL Plasma center near you: https://bit.ly/40PxHup

LinkedInPostImage
LinkedIn
12 Nov

Did you know that even mild iron deficiency may have a big impact on your physical performance? Whether you're a weekend warrior or a professional athlete, iron plays a crucial role in your energy levels and endurance. 🏃‍♀️ Iron is essential for transporting oxygen throughout your body, which powers your muscles during exercise. Without enough iron, you may feel fatigued more quickly and struggle to perform at your best. Learn more about how iron affects performance and how to take charge of your iron health https://bit.ly/3O4MU2X #IronHealth #Fitness #Performance #TakeIronSeriously #IronDeficiencyDay2024

LinkedInPostImage
LinkedIn
11 Nov

At CSL, we are focused on hiring and developing Veterans. We have a Veterans internship program in our Holly Springs, North Carolina site as an industry partner in NC Biotech’s Military Outreach & Veteran’s Engagement \(MOVE\) with a goal of providing internships that lead to offers of full-time employment once the military rotations are completed. Pictured below \(left to right\): Veterans and CSL employees at our Kankakee, Illinois site, Tony Shock, Lead Production Supervisor, Steven Sanders, Senior Manufacturing Manager, and Dave Atkinson Associate Director, Quality Value Stream Lead-Bulk, as they stand in front of a wall honoring 54 current Kankakee employees who have served in the military. https://bit.ly/3O3f921 #VeteransDay #CSL

LinkedInPostImage
LinkedIn
8 Nov

CSL and Sanofi have published a policy position in Frontiers in Medicine to drive transparency in how the FDA considers patient-experience data for regulatory decisions. The article highlights the importance of patients’ needs and perspectives in development and benefit risk assessment and discusses how governing bodies should use that information in regulatory decisions. Read more: https://bit.ly/48E7tgd #CSL

LinkedIn
8 Nov

Alpha 1 antitrypsin deficiency, often called Alpha 1, is a genetic condition where the body does not produce enough of the alpha 1 antitrypsin \(AAT\) protein. This deficiency can lead to serious lung and liver diseases. It’s estimated that 116 million people worldwide are carriers of abnormal Alpha 1 genes. November is Alpha-1 Awareness Month in the U.S. Learn more about the disease, its symptoms, diagnosis and available treatments here: https://bit.ly/3NW2NJ4

LinkedIn
7 Nov

The application period for the Prof. Heimburger Award 2025 has been extended to November 18, 2024; 11:59pm CET! The Award celebrates early career researchers within the fields of acquired and inherited bleeding disorders. • Five global research grants of €25,000 are given out each year • The awards are reserved for researchers who hold a medical degree or a PhD and are available for clinical and preclinical research in the areas of inherited and acquired bleeding disorders • Applicants who have less than five years post-doctoral research experience or clinical practice experience will be prioritized • Applications must be received by November 18, 2024; 11:59pm CET, to be considered To apply, or for more information, visit: https://bit.ly/40xe7CU

LinkedInPostImage

We Are CSL

  • Our Businesses and Products
  • Vita: Original Stories
  • Our Leadership
  • Worldwide Locations
  • Corporate Governance

Patients & Public Health

  • Rare & Serious Diseases
  • Iron Deficiency
  • Nephrology
  • Vaccines
  • Patient Support & Organizations

R&D

  • R&D Capabilities
  • Awards, Grants and Initiatives
  • World-Class R&D Network
  • Product Pipeline
  • Clinical Studies at CSL

Sustainability

  • Healthier Environment
  • Healthier Communities
  • Promising Futures
  • Governance
  • Data and Reporting Centre

Careers

  • Diversity, Equity & Inclusion
  • How CSL Supports Your Well-being
  • Early Careers at CSL

Investors

Terms of Use Cookie Policy Global Privacy Policy Accessibility Statement Sitemap
  • Terms of Use
  • Cookie Policy
  • Global Privacy Policy
  • Accessibility Statement
  • Sitemap
CSL logo

CSL, All Rights Reserved © 2024

  • Instagram

CSL
  • CSL (CSL Behring's Parent Company)
CSL Behring Worldwide

Americas

  • Argentina
  • Brazil
  • Canada
  • Chile
  • Colombia
  • Mexico

Asia Pacific

  • Australia
  • China
  • Japan
  • Korea
  • Singapore
  • Taiwan

Middle East

  • Saudi Arabia
  • United Arab Emirates (MEA)

Europe

  • Austria
  • Belgium and Luxembourg
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Iceland
  • Italy
  • Netherlands
  • Norway
  • Poland
  • Slovakia
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Kingdom
CSL Plasma (CSL Behring Subsidiary)
  • CSL Plasma US
  • CSL Plasma Germany
  • CSL Plasma Hungary